减持

Search documents
甘李药业实控人方上周减持85万股 上市5年2募资共33亿
Zhong Guo Jing Ji Wang· 2025-04-28 07:21
Core Points - Gannee Pharmaceutical recently disclosed a significant change in shareholder equity, with Beijing Xute Hongda Technology Co., Ltd. reducing its stake in the company [1][2] - The equity change period was from April 22, 2025, to April 24, 2025, during which Xute Hongda reduced its holdings by 849,822 shares, representing 0.14% of Gannee's total share capital [1][2] - After the change, Xute Hongda holds 40,634,035 shares, accounting for 6.76% of Gannee's total share capital, while its concerted actor, Gan Zhongru, holds 205,643,757 shares, representing 34.21% [1][2] Company Information - Gan Zhongru is the largest shareholder of Gannee Pharmaceutical, while Xute Hongda is the second largest shareholder [2] - Gan Zhongru has been the controlling shareholder and actual controller of Gannee since 2020, serving as the chairman of the company [2] - Gannee Pharmaceutical was listed on the Shanghai Stock Exchange on June 29, 2020, with an initial public offering (IPO) of 40.2 million shares at a price of 63.32 yuan per share [2][3] Fundraising Activities - Gannee Pharmaceutical raised a total of 2.545 billion yuan through its IPO, with a net amount of 2.441 billion yuan after expenses [2][3] - The funds raised were intended for various projects, including marketing network construction and the registration of insulin products in the U.S. [2] - In 2023, Gannee issued 28,508,550 shares at a price of 27.12 yuan per share, raising approximately 773.15 million yuan, with a net amount of about 759.73 million yuan after expenses [3]
华立科技拟定增募不超1.49亿 外籍实控人去年底减持
Zhong Guo Jing Ji Wang· 2025-04-28 02:45
中国经济网北京4月28日讯华立科技(301011)(301011.SZ)25日晚披露《2025年度以简易程序向特定对 象发行股票预案》称,本次发行的发行对象不超过35名(含本数),为符合中国证监会规定的特定投资 者,包括符合中国证监会规定的证券投资基金管理公司、证券公司、信托投资公司、财务公司、保险机 构投资者、合格境外机构投资者,以及符合中国证监会规定的其他法人、自然人或其他合格的投资者。 其中,证券投资基金管理公司、证券公司、合格境外机构投资者、人民币合格境外机构投资者以其管理 的两只以上产品认购的,视为一个发行对象;信托投资公司作为发行对象的,只能以自有资金认购。所 有发行对象均以现金方式认购本次发行的股票。 本次发行的定价基准日为发行期首日,发行价格不低于定价基准日前20个交易日公司股票均价的80%。 本次发行的股票种类为境内上市的人民币普通股(A股),每股面值为人民币1.00元。本次发行的股票将 在深圳证券交易所创业板上市。本次发行的股票数量按照募集资金总额除以发行价格确定,不超过本次 发行前公司总股本的30%。 本次发行拟募集资金总额不超过14,860.00万元(含本数),不超过人民币3亿元且不超 ...
品渥食品持股超5%股东吴柏赓拟减持不超3%股份 套现需求几何?
Xin Lang Cai Jing· 2025-04-27 08:49
减持目的与承诺履行 品渥食品近日发布一则股东减持计划预披露公告,持股5%以上股东吴柏赓计划在特定时间内减持公司 部分股份。这一举动引发市场关注,究竟是何原因促使股东减持,对公司又将产生何种影响? 减持计划详情 截至公告披露日,吴柏赓持有品渥食品14,222,300股,占公司总股本比例14.37%(总股本按剔除公司回 购专用账户中的股份数量996,252股计算)。他计划在减持计划公告之日起15个交易日后的3个月内,即 2025年5月22日至2025年8月21日,通过集中竞价交易、大宗交易方式减持公司股份合计不超过2,970,111 股,即不超过公司总股本的3% 。 其中,通过集中竞价交易方式减持时,在任意连续90个自然日内减持股份的总数不超过公司股份总数的 1%。减持价格将根据减持时的二级市场价格及交易方式确定。若计划减持期间公司有送股、配股、资 本公积金转增股本等除权除息事项,减持数量将相应调整,减持比例保持不变。 虽然吴柏赓此次减持计划符合相关法律法规要求,但仍存在一定不确定性。他将根据市场情况、公司股 价情况等决定是否实施本次股份减持计划,减持时间、减持价格等实施细节存在变数。 从对公司影响来看,尽管公告 ...
世纪恒通科技股份有限公司
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-04-27 08:18
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:301428 证券简称:世纪恒通 公告编号:2025-024 世纪恒通科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、 误导性陈述或重大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经过审计 □是 √否 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 ■ 其他符合非经常性损益定义的损益项目的具体情况 √适用 □不适用 单位:元 ■ 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告第1号一一非经常 ...
指数是否会二次探底?4月26日,今日凌晨的三大重要消息正式出炉
Sou Hu Cai Jing· 2025-04-26 18:23
Group 1 - The China Securities Regulatory Commission announced that the A-shares market will be closed from May 1, 2025, to May 5, 2025, for a total of 5 days, with trading resuming on May 6, 2025 [1] - There is ongoing concern regarding quantitative easing and major shareholder reductions, which are causing uncertainty in the market [1] - The market is expected to either break upwards or return to a central range, but the lack of clarity around quantitative measures and shareholder actions is creating a cautious atmosphere [1] Group 2 - The overall market sentiment is characterized by stability, but trading volume remains low, leading to a slow upward grind without significant volume increases [3] - There has been a notable outflow of capital from the Hong Kong market, with a record net outflow of 18 billion, indicating a potential shift in investor sentiment [3] - The banking sector has shown volatility, impacting market emotions, but if sufficient capital influx occurs, it could stabilize the index and invigorate other sectors [5] Group 3 - The Shanghai Composite Index experienced a slight decline of 0.07%, while the power sector saw a significant surge [7] - The market has been hovering below a gap without making significant upward movements, but there is resilience as funds are being reinvested during downturns [7] - Investors are advised to hold onto their positions during low market phases rather than attempting to time the market for the lowest entry points [7]
博盈特焊:股东拟合计减持不超5%公司股份
news flash· 2025-04-25 17:02
博盈特焊(301468)公告,合计持股5%以上的股东前海股权投资基金(有限合伙)、中原前海股权投资基 金(有限合伙)及深圳润信新观象战略新兴产业私募股权投资基金合伙企业(有限合伙)计划自公告日起15 个交易日后2个月内,以集中竞价和大宗交易方式合计减持公司股份不超过394.5万股和263万股,分别 占剔除回购股份后公司总股本的3%和2%。减持原因为自身经营需要,减持价格将按市场价格确定。 ...
温州源飞宠物玩具制品股份有限公司关于股东减持股份预披露公告
Shang Hai Zheng Quan Bao· 2025-04-23 19:28
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:001222 证券简称:源飞宠物 公告编号:2025-004 温州源飞宠物玩具制品股份有限公司关于股东减持股份预披露公告 公司股东平阳县晟洵创业投资合伙企业(有限合伙)保证向本公司提供的信息内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告的内容与信息披露义务人提供的信息一致。 特别提示: 持有公司股份6,072,300股(占本公司总股本比例3.22%)(总股本以公司当前总股本剔除已回购股份后 的股份数量188,380,460股为计算依据,下同)的股东平阳县晟洵创业投资合伙企业(有限合伙)计划以 集中竞价交易或大宗交易方式减持其持有的本公司股份不超过5,651,413股(不超过本公司总股本比例 3%); 上述股东以集中竞价交易方式或大宗交易方式减持公司股份的,自本减持计划公告之日起15个交易日后 的3个月内(2025年5月20日至2025年8月19日)进行(如遇送股、资本公积金转增股本等股份变动事 项,上述拟减持股份数量将做相应调整)。 温州源飞宠物玩具制品股份有限公司(以下简称"公司"或"本公司")于近日收 ...
神州细胞6家员工持股平台拟减持 连亏8年后2024年扭亏
Zhong Guo Jing Ji Wang· 2025-04-23 06:05
Core Viewpoint - Shenzhou Cell (688520.SH) announced a share reduction plan involving six shareholders and employee stock ownership platforms, indicating a potential shift in shareholder dynamics and liquidity in the market [1][3]. Shareholder Reduction Plan - Six shareholders, including various management consulting partnerships, plan to reduce their holdings by up to 2,061,010 shares, representing no more than 0.50% of the total share capital, within three months after the announcement [3]. - The shareholders involved hold a combined total of 36,500,000 shares, accounting for 8.20% of the company's total share capital [2]. Financial Performance - For the fiscal year 2023, Shenzhou Cell reported total revenue of 2.513 billion yuan, a year-on-year increase of 33.13% [5][6]. - The net profit attributable to the parent company was 112 million yuan, a significant recovery from a net loss of 396 million yuan in the previous year [5][6]. - The company had previously experienced eight consecutive years of losses, with net profits from 2016 to 2023 showing a downward trend until the recent turnaround [7]. Shareholder Commitment - The controlling shareholder and actual controller have committed not to participate in the current share reduction plan, ensuring stability in their holdings during this period [4].
破发股索宝蛋白股东拟减持 2023年上市超募4.2亿元
Zhong Guo Jing Ji Wang· 2025-04-23 05:58
Group 1 - Shanghai Bunge plans to reduce its stake in Suobao Protein by up to 5,743,615 shares, representing no more than 3% of the total share capital [1] - The reduction will occur through a combination of centralized bidding and block trading, with a maximum of 1,914,500 shares (1% of total share capital) through centralized bidding and 3,829,115 shares (2% of total share capital) through block trading [1] - As of the announcement date, Shanghai Bunge holds 7,179,715 shares, accounting for 3.75% of the total share capital, all of which were acquired before the company's IPO [1] Group 2 - Suobao Protein was listed on the Shanghai Stock Exchange on December 15, 2023, with an issuance of 47,864,800 shares at a price of 21.29 yuan per share, raising a total of 1,019.04 million yuan [2] - The net proceeds from the offering amounted to 979.46 million yuan, exceeding the original plan by 424.87 million yuan [2] - The funds raised will be allocated to the construction of a 30,000-ton soybean textured protein production line, a 5,000-ton soybean granular protein production line, a 75T medium-temperature and medium-pressure efficient coal powder boiler project, and to supplement working capital [2]
减持速报 | 恒勃股份(301225.SZ)两股东合计拟减持逾3%,福鞍股份(603315.SH)姚晓勇拟减持3%
Xin Lang Cai Jing· 2025-04-23 03:45
1. 迅安科技(834950):员工持股平台迅和管理计划15个交易日后至7月28日止,通过集中竞价或大宗交 易减持不高于2%的股份。 2. 优宁维(301166):股东泰礼投资及一致行动人含泰投资计划15个交易日后3个月内,通过集中竞价或 大宗交易减持不超过3%的股份。 3. 惠云钛业(300891):控股股东一致行动人美国万邦减持计划期限届满,累计减持2.32%股份。 4. 恒勃股份(301225):股东启鸿投资和宁波明序计划15个交易日后3个月内分别减持不高于0.09%和3% 的股份。 5. 华立科技(301011):特定股东致远投资计划15个交易日后3个月内减持不高于0.82%的股份。 6. 德必集团(300947):持股5%以上股东长兴乾悦计划15个交易日后3个月内减持不高于1%的股份。 7. 凡拓数创(301313):部分董事及高管股份减持计划期限届满,累计减持0.66%股份。 8. 镇洋发展(603213):股东汇海合伙、海江合伙减持计划期间届满,分别累计减持0.24%、0.25%股份。 9. 保隆科技(603197):高级管理人员尹术飞、文剑峰减持计划时间届满,分别减持0.0466%、0.039 ...